Highlights from ESMO 2024: How does it affect drug development going forward

Our expert oncologists and regulatory leaders delve into the key highlights from the recent European Society for Medical Oncology (ESMO) Congress. This session explores groundbreaking research, innovative treatment approaches, and pivotal clinical trial results presented at ESMO. Our speakers analyze how these developments may influence the strategies of other drug developers, potentially reshaping the landscape of oncology research and treatment. 

Return to Insights Center